Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(25.0%)
N/A
1(25.0%)
Phase 2
1(25.0%)
Phase 3
1(25.0%)
4Total
Phase 4(1)
N/A(1)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02581371Phase 4Unknown

Comprehensive Reparative Therapy in Ischemic Stroke COMplex Repair in Ischemic Stroke-Arm

Role: lead

NCT00901381Phase 2Completed

Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke

Role: lead

NCT01467908Not ApplicableCompleted

Navigated Brain Stimulation in Diagnosis of Minimally Conscious State

Role: lead

NCT01388738Phase 3Completed

Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.

Role: lead

NCT00893633Completed

Critical Illness Neuromuscular Abnormalities in Neurocritical Care Patients

Role: lead

All 5 trials loaded